IL133443A0 - Use of yohimibine arginine in the preparation of a drug for treating erectile dysfunctions and a drug for treating same - Google Patents

Use of yohimibine arginine in the preparation of a drug for treating erectile dysfunctions and a drug for treating same

Info

Publication number
IL133443A0
IL133443A0 IL13344398A IL13344398A IL133443A0 IL 133443 A0 IL133443 A0 IL 133443A0 IL 13344398 A IL13344398 A IL 13344398A IL 13344398 A IL13344398 A IL 13344398A IL 133443 A0 IL133443 A0 IL 133443A0
Authority
IL
Israel
Prior art keywords
drug
treating
arginine
yohimibine
preparation
Prior art date
Application number
IL13344398A
Other languages
English (en)
Original Assignee
Real 2000 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Real 2000 Ltd filed Critical Real 2000 Ltd
Publication of IL133443A0 publication Critical patent/IL133443A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13344398A 1997-07-04 1998-07-06 Use of yohimibine arginine in the preparation of a drug for treating erectile dysfunctions and a drug for treating same IL133443A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708504A FR2765483B1 (fr) 1997-07-04 1997-07-04 Medicament destine a traiter les dysfonctions erectiles
PCT/FR1998/001438 WO1999001132A1 (fr) 1997-07-04 1998-07-06 Medicament, contenant de la yohimbine et de l'arginine, destine a traiter les dysfonctions erectiles

Publications (1)

Publication Number Publication Date
IL133443A0 true IL133443A0 (en) 2001-04-30

Family

ID=9508874

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13344398A IL133443A0 (en) 1997-07-04 1998-07-06 Use of yohimibine arginine in the preparation of a drug for treating erectile dysfunctions and a drug for treating same

Country Status (17)

Country Link
US (1) US20020155136A1 (zh)
EP (1) EP1001775B1 (zh)
JP (1) JP2002511875A (zh)
KR (1) KR20010021505A (zh)
CN (1) CN1261798A (zh)
AT (1) ATE212841T1 (zh)
AU (1) AU743825B2 (zh)
BR (1) BR9810981A (zh)
CA (1) CA2295916A1 (zh)
DE (1) DE69803773T2 (zh)
DK (1) DK1001775T3 (zh)
ES (1) ES2172171T3 (zh)
FR (1) FR2765483B1 (zh)
ID (1) ID24184A (zh)
IL (1) IL133443A0 (zh)
PT (1) PT1001775E (zh)
WO (1) WO1999001132A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
DE19831263A1 (de) 1998-07-11 2000-01-13 Lohmann Therapie Syst Lts Darreichungsform
DE60026146T2 (de) * 1999-09-03 2006-08-17 Apbi Holdings, Llc Verwendung von Dapoxetin, A selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Disfunktion
SI1086695T1 (en) * 1999-09-21 2005-06-30 Enzo Leone Antiviral compositions comprising yohimbine as active principle
AU2001282373A1 (en) * 2000-05-26 2001-12-03 Horphag Research Limited Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
ITMI20020990A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
ITMI20020994A1 (it) * 2002-05-10 2003-11-10 Indena Spa Formulazioni utili nel trattamento dell'impotenza maschile e femminile
HUP0401422A2 (en) 2004-07-15 2006-04-28 G Laszlo Meszaros Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
DE102005053241A1 (de) * 2005-11-08 2007-05-16 Schwabe Willmar Gmbh & Co Extrakte aus der Rinde von Corynanthe-Arten und deren Verwendung sowie diese Extrakte enthaltende Arzneimittel, diätetische Lebensmittel und pharmazeutische Zubereitungen
CN111840508A (zh) * 2020-07-17 2020-10-30 北京清大赛尔生物科技有限公司 一种预防及治疗男性性功能障碍的外用制剂及其应用
CN113116905A (zh) * 2021-04-20 2021-07-16 北京天玺宝科技有限公司 一种增强男性性功能并持续改善性功能障碍的组合物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response

Also Published As

Publication number Publication date
EP1001775B1 (fr) 2002-02-06
ATE212841T1 (de) 2002-02-15
CN1261798A (zh) 2000-08-02
FR2765483B1 (fr) 2000-02-04
KR20010021505A (ko) 2001-03-15
EP1001775A1 (fr) 2000-05-24
ID24184A (id) 2000-07-13
DE69803773T2 (de) 2002-08-29
AU8446798A (en) 1999-01-25
FR2765483A1 (fr) 1999-01-08
JP2002511875A (ja) 2002-04-16
DK1001775T3 (da) 2002-04-29
ES2172171T3 (es) 2002-09-16
PT1001775E (pt) 2002-07-31
WO1999001132A1 (fr) 1999-01-14
CA2295916A1 (en) 1999-01-14
US20020155136A1 (en) 2002-10-24
AU743825B2 (en) 2002-02-07
DE69803773D1 (de) 2002-03-21
BR9810981A (pt) 2000-08-15

Similar Documents

Publication Publication Date Title
IL133443A0 (en) Use of yohimibine arginine in the preparation of a drug for treating erectile dysfunctions and a drug for treating same
EP0783299A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
IL111734A0 (en) Compositions for the preparation of in vivo therapeutic products
EP1015008A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES
HUP9903613A3 (en) Improvement in the taste of active pharmaceutical ingredients
HK1036970A1 (en) Compounds and compositions for delivering active agents.
IL140930A0 (en) Compounds and compositions for delivering active agents
CZ20012028A3 (cs) Nové N-substituované 2-kyanopyrrolidiny, farmaceutický prostředek, který je obsahuje a jejich použití jako léčivo
HK1024865A1 (en) Pharmaceutical compositions comprising a mixture of autocross-linked hyaluronic acid and nonautocross-linked hyaluronic acid and their use for the treatment of arthropathies
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
YU33099A (sh) Farmaceutska smesa za poboljšanje erektilne disfunkcije kod muškaraca
GR3034162T3 (en) Liposome-encapsulated taxol, its preparation and its use
ZA944347B (en) The use of cetrorelix and other nona- and decapeptides in the preparation of a medicament for combating aids and for growth stimulation
MY125978A (en) Admantane derivatives
ATE311373T1 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
EP0672052A1 (en) TACHYQUININ ANTAGONISTS, THEIR PRODUCTION AND THEIR USE IN PHARMACEUTICAL FORMULATIONS.
EP1037918A4 (en) METHOD AND COMPOSITIONS FOR INCREASING THE EFFICIENCY OF VACCINALS USING CHEMOKINES
WO2001085188A3 (en) Use of echinacea as a hematinic agent
NZ525774A (en) Use of SARP-1 for the treatment and/or prevention of scleroderma
IL89816A (en) Synergistically active veterinary compositions containing polymyxin b and chlorquinaldol, their preparation and use
AR242556A1 (es) Procedimiento para la obtencion de derivados de la benzamidina.
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
OA09771A (en) Asphodelus composition for increasing white blood cell count.
HK1058305A1 (en) Combinations of dalfopristine/quinupristine with cefpirome